Atrial Fibrillation

Patients’ views about screening for atrial fibrillation (AF): a qualitative study in primary care
Mark Lown, Christopher R Wilcox, Stephanie Hughes, Miriam Santer, George Lewith, Michael Moore, Paul Little

BMJ Open Mar 2020, 10 (3) e033061; DOI: 10.1136/bmjopen-2019-033061
A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland
Giorgio Ciminata, Claudia Geue, Peter Langhorne, Olivia Wu

BMJ Open Mar 2020, 10 (3) e028575; DOI: 10.1136/bmjopen-2018-028575
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
Linda P T Joosten, Sander van Doorn, Arno W Hoes, Melchior C Nierman, Nynke M Wiersma, Huiberdina L Koek, Martin E W Hemels, Menno V Huisman, Kit C Roes, Rutger M van den Bor, Wim F Buding, Frans H Rutten, Geert-Jan Geersing

BMJ Open Dec 2019, 9 (12) e032488; DOI: 10.1136/bmjopen-2019-032488
Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database
Anneka Mitchell, Tomas J Welsh, Margaret C Watson, Julia Snowball, Anita McGrogan

BMJ Open Dec 2019, 9 (12) e032646; DOI: 10.1136/bmjopen-2019-032646
Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
José Miguel Rivera-Caravaca, Francisco Marín, María Asunción Esteve-Pastor, Josefa Gálvez, Gregory Y.H. Lip, Vicente Vicente, Vanessa Roldán

BMJ Open Dec 2019, 9 (12) e033712; DOI: 10.1136/bmjopen-2019-033712
Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK
Ana Ruigómez, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Luke Roberts, Samuel Fatoba, Oscar Fernandez, Luis Alberto García Rodríguez

BMJ Open Oct 2019, 9 (10) e031342; DOI: 10.1136/bmjopen-2019-031342
A systematic review protocol for examining 30-day readmission costs for atrial fibrillation patients
Taylor-Jade Woods, Peter Speck, Billingsley Kaambwa

BMJ Open Oct 2019, 9 (10) e032101; DOI: 10.1136/bmjopen-2019-032101
A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation
Linlin Mai, Yu Wu, Jianjing Luo, Xinyue Liu, Hailan Zhu, Haoxiao Zheng, Guoquan Liang, Yan Zhang, Yuli Huang

BMJ Open Sep 2019, 9 (9) e031180; DOI: 10.1136/bmjopen-2019-031180
Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure
Lan Gao, Marj Moodie

BMJ Open Sep 2019, 9 (9) e031033; DOI: 10.1136/bmjopen-2019-031033
Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study
Pei-Ti Chen, Tsae-Jyy Wang, Ming-Hsiung Hsieh, Ju-Chi Liu, Chieh-Yu Liu, Kwua-Yun Wang, Wen-Chun Laio

BMJ Open Sep 2019, 9 (9) e029974; DOI: 10.1136/bmjopen-2019-029974

Main menu

Atrial Fibrillation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Atrial Fibrillation

Pages